These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19669257)

  • 1. Current therapy for hepatitis C or D or immunodeficiency virus concurrent infection with chronic hepatitis B.
    Chien RN
    Hepatol Int; 2008 Sep; 2(3):296-303. PubMed ID: 19669257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
    Boyd A; Lacombe K; Miailhes P; Gozlan J; Bonnard P; Molina JM; Lascoux-Combe C; Serfaty L; Gault E; Desvarieux M; Girard PM
    J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infection.
    Hung CH; Lee CM; Lu SN; Wang JH; Tung HD; Chen CH; Changchien CS
    J Gastroenterol Hepatol; 2005 May; 20(5):727-32. PubMed ID: 15853986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis D, B and C virus (HDV/HBV/HCV) coinfection as a diagnostic problem and therapeutic challenge.
    Lorenc B; Sikorska K; Stalke P; Bielawski K; Ziętkowski D
    Clin Exp Hepatol; 2017 Mar; 3(1):23-27. PubMed ID: 28856286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter study of viral hepatitis in a United States hemophilic population.
    Troisi CL; Hollinger FB; Hoots WK; Contant C; Gill J; Ragni M; Parmley R; Sexauer C; Gomperts E; Buchanan G
    Blood; 1993 Jan; 81(2):412-8. PubMed ID: 7678517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanisms.
    Lucifora J; Alfaiate D; Pons C; Michelet M; Ramirez R; Fusil F; Amirache F; Rossi A; Legrand AF; Charles E; Vegna S; Farhat R; Rivoire M; Passot G; Gadot N; Testoni B; Bach C; Baumert TF; Hyrina A; Beran RK; Zoulim F; Boonstra A; Büning H; Verrier ER; Cosset FL; Fletcher SP; Salvetti A; Durantel D
    J Hepatol; 2023 May; 78(5):958-970. PubMed ID: 36702177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis delta-associated mortality in HIV/HBV-coinfected patients.
    Béguelin C; Moradpour D; Sahli R; Suter-Riniker F; Lüthi A; Cavassini M; Günthard HF; Battegay M; Bernasconi E; Schmid P; Calmy A; Braun DL; Furrer H; Rauch A; Wandeler G;
    J Hepatol; 2017 Feb; 66(2):297-303. PubMed ID: 27746337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers.
    Liaw YF; Tsai SL; Sheen IS; Chao M; Yeh CT; Hsieh SY; Chu CM
    Am J Gastroenterol; 1998 Mar; 93(3):354-9. PubMed ID: 9517639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.
    Chen LW; Chien RN; Yen CL; Chang JJ; Liu CJ; Lin CL
    J Gastroenterol Hepatol; 2010 Feb; 25(2):259-63. PubMed ID: 19817959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment.
    Chu CJ; Lee SD
    J Gastroenterol Hepatol; 2008 Apr; 23(4):512-20. PubMed ID: 18397482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hepatitis C virus in dual and triple hepatitis virus infection.
    Liaw YF
    Hepatology; 1995 Oct; 22(4 Pt 1):1101-8. PubMed ID: 7557857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Discussion on optimal duration of pegylated interferon α combined with ribavirin for chronic hepatitis C in HIV-infected patients].
    Ke YC; Li LH; Hu FY; Lan Y; He YZ; Chen XJ; Tang XP; Cai WP; Lu RC; He Y; Li HQ
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):282-287. PubMed ID: 29996340
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of human immunodeficiency virus infection on hepatitis delta virus superinfection in chronic HBsAg carriers.
    Pol S; Wesenfelder L; Dubois F; Roingeard P; Carnot F; Driss F; Brechot C; Goudeau A; Berthelot P
    J Viral Hepat; 1994; 1(2):131-7. PubMed ID: 8790568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis viruses and liver transplantation.
    Samuel D; Feray C; Bismuth H
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection.
    Liu CJ; Chen PJ
    World J Gastroenterol; 2014 Mar; 20(11):2955-61. PubMed ID: 24659886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients.
    Hung CH; Lu SN; Wang JH; Hu TH; Chen CH; Huang CM; Lee CM
    Antivir Ther; 2011; 16(7):959-68. PubMed ID: 22024511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
    Kumar R; Singla V; Kacharya Sk
    Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic hepatitis B: case selection and duration of therapy.
    Leung N
    J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.